Alpha 2A-adrenoceptor-specific stimulation of [35S]GTP gamma S binding to membrane preparations of rat frontal cortex
- PMID: 17786553
- DOI: 10.1007/s11064-007-9457-z
Alpha 2A-adrenoceptor-specific stimulation of [35S]GTP gamma S binding to membrane preparations of rat frontal cortex
Abstract
Functional activation of alpha 2A adrenergic receptors in the crude membranes from rat frontal cortex was studied by a [35S]-guanosine 5'-O-(gamma-thiotriphosphate) ([35S]GTP gamma S) binding assay. alpha 2A agonists UK14304 and guanfacine decreased the ability of GDP to compete with [35S]GTP gamma S binding to the membranes and 0.1 mM GDP was found to be optimal for the following functional experiments. However, even after careful optimization of experimental conditions the specificity of ligands for rat alpha 2 adrenoceptors were not sufficient, as agonists as well as antagonists became activators of other signal transduction systems before achieving their maximal effect in the alpha 2A-adrenergic system. Only using compromising concentration of agonist (up to 1 microM UK14304) and antagonist (up to 1 microM RS79948) to inhibit agonist's effect, allowed us to filtrate out alpha 2A specific effect for characterization of signal transduction in rat frontal cortex membranes for the comparison efficacies of this system for different animals from behavioral experiments.
Similar articles
-
Chronic fluoxetine reverses the effects of chronic corticosterone treatment on α2-adrenoceptors in the rat frontal cortex but not locus coeruleus.Neuropharmacology. 2019 Nov 1;158:107731. doi: 10.1016/j.neuropharm.2019.107731. Epub 2019 Jul 31. Neuropharmacology. 2019. PMID: 31376424
-
Pharmacological characterization of alpha2D-adrenergic receptor-mediated [35S]GTPgammaS binding in rat cerebral cortical membranes.Pharmacol Res. 2008 Jun;57(6):435-44. doi: 10.1016/j.phrs.2008.04.006. Epub 2008 Apr 26. Pharmacol Res. 2008. PMID: 18515144
-
Dissimilar pharmacological responses by a new series of imidazoline derivatives at precoupled and ligand-activated alpha 2A-adrenoceptor states: evidence for effector pathway-dependent differential antagonism.J Pharmacol Exp Ther. 2003 Jun;305(3):1015-23. doi: 10.1124/jpet.102.048215. Epub 2003 Mar 20. J Pharmacol Exp Ther. 2003. PMID: 12649300
-
Agonists and antagonists targeting the different alpha2-adrenoceptor subtypes.Curr Top Med Chem. 2007;7(2):163-86. doi: 10.2174/156802607779318235. Curr Top Med Chem. 2007. PMID: 17266604 Review.
-
Potential noradrenergic targets for cognitive enhancement in schizophrenia.CNS Spectr. 2004 May;9(5):350-5. doi: 10.1017/s1092852900009330. CNS Spectr. 2004. PMID: 15115947 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources